SBRT 2016

JCO 2008

Prospective phase II study with 70 patients SBRT with very high irradiation doses of up to 3 x 22Gy

peripheral

central

Freedom from ≥ grade 3 toxicity

M Guckenberger - SBRT stage I NSCLC - HICARE 2015

20

/